A wave of new clinical trial results is bringing cautious optimism to advanced cancer care, with promising data emerging across pancreatic, bowel, rectal, breast, and bladder cancers. Researchers ...

The Philadelphia Walk to End Bladder Cancer is raising awareness for a disease doctors say is often overlooked.

Every patient in a small clinical trial at Memorial Sloan Kettering Cancer Center saw their rectal cancer vanish after ...

Non-muscle-invasive bladder cancer (NMIBC) has a high risk of recurrence and progression among patients without adequate Bacillus Calmette-Guérin.

Recent advances in biomedical technologies—including microphysiological systems (MPS), humanized and chimeric animal models, nanomaterials, cell-based ...

Bladder cancer survivors and local health leaders are rallying the Cincinnati community for the city’s first Walk to End ...

In a phase 2 study, researchers added pembrolizumab to chemoradiation and surgery for muscle-invasive bladder cancer. 60 ...

New Urine Test Could Predict Response To Bladder Cancer Treatment. Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has residual bladder cancer after ...

A drug that helps the immune system find cancer cells also helps patients avoid having their bladders surgically removed ...

Flaig: It has been a remarkable 10 years for bladder cancer. If you think back to 10 or 15 years ago, we had no new ...

A drug that helps the immune system find cancer cells also helps patients avoid having their bladders surgically removed (cystectomy), a new study shows.

A drug that helps the immune system find cancer cells also helps patients avoid having their bladders surgically removed (cystectomy), a new study ...